MX2016012536A - Rnasa para su uso en el tratamiento o la prevencion de infecciones virales. - Google Patents
Rnasa para su uso en el tratamiento o la prevencion de infecciones virales.Info
- Publication number
- MX2016012536A MX2016012536A MX2016012536A MX2016012536A MX2016012536A MX 2016012536 A MX2016012536 A MX 2016012536A MX 2016012536 A MX2016012536 A MX 2016012536A MX 2016012536 A MX2016012536 A MX 2016012536A MX 2016012536 A MX2016012536 A MX 2016012536A
- Authority
- MX
- Mexico
- Prior art keywords
- viral infections
- onconase
- treating
- preventing viral
- ribonucleases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/27—Endoribonucleases producing 3'-phosphomonoesters (3.1.27)
- C12Y301/27005—Pancreatic ribonuclease (3.1.27.5)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Las ribonucleasas de la súper familia RNasa A o un derivado funcional de las mismas son ampliamente útiles para el tratamiento o prevención de las infecciones virales causadas por los virus clasificados en los Grupos I, II, IV y V de Baltimore en sujetos mamíferos.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201414229816A | 2014-03-28 | 2014-03-28 | |
US201414247723A | 2014-04-08 | 2014-04-08 | |
US201414316893A | 2014-06-27 | 2014-06-27 | |
US201462040885P | 2014-08-22 | 2014-08-22 | |
US201462063551P | 2014-10-14 | 2014-10-14 | |
US201562102671P | 2015-01-13 | 2015-01-13 | |
US201514667282A | 2015-03-24 | 2015-03-24 | |
PCT/US2015/022670 WO2015148768A2 (en) | 2014-03-28 | 2015-03-26 | Rnase for use in treating or preventing viral infections |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016012536A true MX2016012536A (es) | 2017-04-06 |
Family
ID=53284490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016012536A MX2016012536A (es) | 2014-03-28 | 2015-03-26 | Rnasa para su uso en el tratamiento o la prevencion de infecciones virales. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3122372B1 (es) |
JP (1) | JP2017512837A (es) |
AU (1) | AU2015236040B2 (es) |
BR (1) | BR112016022214A2 (es) |
CA (2) | CA3061666C (es) |
CL (1) | CL2016002442A1 (es) |
IL (1) | IL247938A0 (es) |
MX (1) | MX2016012536A (es) |
WO (1) | WO2015148768A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9919034B2 (en) | 2014-03-28 | 2018-03-20 | Tamir Biotechnology, Inc. | Methods of treating and prophylactically protecting mammalian patients infected by viruses classified in Baltimore group V |
US10835598B2 (en) | 2014-08-18 | 2020-11-17 | Orgenesis Inc. | Prophylactic protection against viral infections, particularly HIV |
MX2017016368A (es) | 2015-06-15 | 2018-04-24 | Tamir Biotechnology Inc | Farmaceuticos para tratamiento de infecciones virales de los ojos. |
MX2018003528A (es) * | 2015-09-25 | 2018-11-09 | Okogen Inc | Tratamiento de conjuntivitis viral utilizando ranpirnasa y/o anfinasa. |
WO2017142807A1 (en) * | 2016-02-16 | 2017-08-24 | Tamir Biotechnology, Inc. | Treatment or prevention of zika virus infections by administration of a ribonuclease |
WO2021188854A1 (en) * | 2020-03-20 | 2021-09-23 | Orgenesis Inc. | Ribonucleases for treating viral infections |
MX2023002337A (es) * | 2020-08-27 | 2023-05-12 | Betahealth Llc | Composición y métodos para el tratamiento o profilaxis de coronavirus y cánceres. |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5728805A (en) | 1988-04-06 | 1998-03-17 | Alfacell Corp. | Pharmaceuticals and method for making them |
US5559212A (en) | 1988-04-06 | 1996-09-24 | Alfacell Corporation | Frog embryo and egg-derived tumor cell anti-proliferation protein |
US6239257B1 (en) | 1998-12-30 | 2001-05-29 | Alfacell Corporation | Family of proteins belonging to the pancreatic ribonuclease a superfamily |
US7229824B2 (en) | 2003-07-17 | 2007-06-12 | Alfacell Corporation | Ribonucleases and methods of making them recombinantly |
US7544487B2 (en) * | 2004-02-13 | 2009-06-09 | Immunomedics, Inc. | Fusion proteins containing recombinant cytotoxic RNAses |
EP3613761A1 (en) | 2008-11-26 | 2020-02-26 | Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Virus like particle compositions and methods of use |
US8518399B2 (en) | 2010-11-17 | 2013-08-27 | Tamir Biotechnology, Inc. | Methods of treating infections originating from viruses in the herpesviridae family |
US8663964B2 (en) | 2011-07-20 | 2014-03-04 | Tamir Biotechnology, Inc. | Methods of treating human papillomavirus |
-
2015
- 2015-03-26 CA CA3061666A patent/CA3061666C/en active Active
- 2015-03-26 CA CA2942706A patent/CA2942706C/en active Active
- 2015-03-26 AU AU2015236040A patent/AU2015236040B2/en active Active
- 2015-03-26 JP JP2017502927A patent/JP2017512837A/ja active Pending
- 2015-03-26 EP EP15727086.9A patent/EP3122372B1/en active Active
- 2015-03-26 WO PCT/US2015/022670 patent/WO2015148768A2/en active Application Filing
- 2015-03-26 BR BR112016022214A patent/BR112016022214A2/pt not_active Application Discontinuation
- 2015-03-26 MX MX2016012536A patent/MX2016012536A/es unknown
-
2016
- 2016-09-20 IL IL247938A patent/IL247938A0/en unknown
- 2016-09-28 CL CL2016002442A patent/CL2016002442A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3122372A2 (en) | 2017-02-01 |
CA3061666C (en) | 2021-04-27 |
AU2015236040B2 (en) | 2017-12-07 |
WO2015148768A2 (en) | 2015-10-01 |
AU2015236040A1 (en) | 2016-10-06 |
BR112016022214A2 (pt) | 2017-10-24 |
EP3122372B1 (en) | 2018-11-28 |
IL247938A0 (en) | 2016-11-30 |
WO2015148768A3 (en) | 2015-12-30 |
JP2017512837A (ja) | 2017-05-25 |
CA2942706C (en) | 2020-01-14 |
CA2942706A1 (en) | 2015-10-01 |
CL2016002442A1 (es) | 2017-05-19 |
CA3061666A1 (en) | 2015-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016012536A (es) | Rnasa para su uso en el tratamiento o la prevencion de infecciones virales. | |
MX2020005187A (es) | Compuestos y composiciones farmaceuticas antivirales, asi como metodos de uso de los mismos. | |
MX2017005252A (es) | Metodos para la preparacion de ribosidos. | |
EA201791460A1 (ru) | N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения | |
EP3119418A4 (en) | Methods for increasing red blood cell levels and treating ineffective erythropoiesis by inhibiting activin b and/or gdf11 | |
AU2015286723B2 (en) | Influenza virus vaccines and uses thereof | |
WO2015153889A3 (en) | Materials and methods for the treatment of latent viral infection | |
EP3370754A4 (en) | METHODS FOR INCREASING ERYTHROCYTE RATES AND TREATING INEFFECTIVE ERYTHROPOISIS | |
IL258846A (en) | Nicotinamide for use in the treatment and prevention of optic neurodegenerative disorder | |
EP3474861A4 (en) | COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS. | |
EP3212658A4 (en) | 2',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancer | |
EP3432891A4 (en) | METHOD FOR THE TREATMENT AND PREVENTION OF C. DIFFICILE | |
EP3166615A4 (en) | Methods for the treatment of hepatitis b and hepatitis d virus infections | |
WO2016007540A3 (en) | Compositions and methods for treating dengue virus infection | |
EP3658679A4 (en) | RAPID DETECTION AND ENUMERATION OF VIRUSES, BACTERIOPHAGES AND / OR BACTERIA | |
PH12017500602A1 (en) | Methods for treating ocular conditions | |
MX2017016437A (es) | Metodos de purificacion y/o inactivacion viral. | |
EP3217974A4 (en) | Method for treating, preventing, or reducing the risk of skin infection | |
EP3353304A4 (en) | TREATMENT OF VIRAL CONJUNCTIVITIS WITH RANPIRNASE AND / OR AMPHINASE | |
EP3195140A4 (en) | Malicious message detection and processing | |
PH12017500820A1 (en) | Combination long acting compositions and methods for hepatitis c | |
PH12017500817A1 (en) | Long acting pharmaceutical compositions for hepatitis c | |
EP3261439A4 (en) | METHOD AND MATERIALS FOR TREATING HUMAN IMMUNE WEAKAGE VIRUS INFECTIONS | |
EP3122190A4 (en) | Compositions and related methods for treating and preventing viral and retroviral infections | |
EP3538888A4 (en) | COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER AND METHOD FOR USE THEREOF |